Watch live: U.S. health officials hold Covid briefing as cases and hospitalizations soar again

Watch live: U.S. health officials hold Covid briefing as cases and hospitalizations soar again


[The stream is slated to start at 10:45 a.m. ET. Please refresh the page if you do not see a player above at that time.]

Senior U.S. health officials are holding a Covid-19 press conference for the first time in over a month, as infections and hospitalizations are on the rise as more transmissible omicron subvariants spread across the country.

Dr. Ashish Jha will lead the briefing for the first time in his role as the White House Covid-19 response coordinator. White House chief medical advisor Dr. Anthony Fauci and Centers for Disease Control and Prevention Director Dr. Rochelle Walensky will provide updates as usual.

The U.S. is reporting more than 94,000 new infections daily on average as of Monday, a 25% increase over the week prior, according to data from the CDC. Hospitalizations have also increased 18% over the past week with about 3,000 people admitted with Covid every day on average, according to CDC data.

With infections and hospitalizations rising, the Food and Drug Administration authorized Pfizer booster doses for children ages 5 to 11 this week. The FDA could authorize Covid vaccines for children under age 5, the only group left in the U.S. not eligible, as soon as next month.

CNBC Health & Science

Read CNBC’s latest global coverage of the Covid pandemic:



Source

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to  billion
Health

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion

A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion. OpenEvidence, based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled in $75 million from […]

Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More